Dutch ban khat

January 10, 2012

The Dutch government Tuesday banned the use of khat, a leaf native to East Africa chewed for its stimulant properties mainly by the Netherlands' sizeable Somali community.

"The drug khat is banned," the Dutch Immigration, Health and Justice departments said in a joint statement.

Khat is grown in the Horn of Africa and has for centuries been chewed by users in Ethiopia, Kenya, Somalia and Yemen.

"The problem lies especially within the Somali community, which is much larger than the Kenyan or Yemeni communities within our country," immigration department spokesman Frank Wassenaar told AFP, adding there were about 27,000 Somalis living in the Netherlands.

"If taken in moderation there are no major problems, but an investigation showed it to be problematic among some 10 percent of khat users," leading to health and social issues, added the statement.

An independent report commissioned by the has cited noise, littering and groups of men who "roam the streets perceived as threatening", as some of the effects.

With high unemployment and low education levels, the Dutch Somali community was "late" in terms of integration, the report said.

Imported legally via Amsterdam's Schiphol airport four times a week, khat is distributed throughout the Netherlands but also in Germany, Sweden, Denmark and Norway, it added.

Around 843 tonnes of khat, worth a minimum 14 million euros (U$18 million) passed through Schiphol in 2010, up from 714 tonnes in 2009 and 693 tonnes in 2008.

Britain and the Netherlands currently allow the import, trade and consumption of khat, according to a European Monitoring Centre for Drugs and letter of July last year entitled "Drugs in focus."

Fifteen of the European Union's 27 states and Norway list khat as an illegal narcotic, while in the other , the plant was not subjected to any controls, the EMCDDA letter said.

Explore further: Herbal amphetamine increases risk of death and stroke in those with heart disease

Related Stories

Herbal amphetamine increases risk of death and stroke in those with heart disease

December 12, 2011
Chewing the natural stimulant khat increases the risk of death and stroke in patients with heart disease compared to those who are not users, according to new research in Circulation: Journal of the American Heart Association.

Dutch to ban coffee shops from selling 'strong' cannabis

October 7, 2011
The Dutch government on Friday announced it would ban coffee shops from selling "strong" cannabis whose active chemical ingredient, tetrahydrocannabinol (THC), is higher than 15 percent.

Recommended for you

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.